Письменный Дмитрий Сергеевич

Письменный Дмитрий Сергеевич

Auto-generated profile, based on publicly available information

Письменный Дмитрий Сергеевич

Cancer Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences; Siberian State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2022 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
OPO. V. Pankova
O. V. Pankova
LTLiubov Tashireva
Liubov Tashireva
EREvgeny Rodionov
Evgeny Rodionov
SМS. V. Мiller
S. V. Мiller
TGTatiana Gerashchenko
Tatiana Gerashchenko
VPVladimir Perelmuter
Vladimir Perelmuter
Background. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains poorly understood. In this study we evaluated the feasibility of predicting the risk of distant metastasis and effectiveness of various treatment options for pre- and intraoperative therapy in NSCLC patients with high and low risk of distant metastasis, divided based on the assessment of morphological changes in the epithelium of small bronchi located near the primary tumor.Material and Methods. The study included 171 patients with NSCLC (T1-4N0-3M0). Various premalignant lesions: isolated basal cell hyperplasia (BCH+SM-D-), basal cell hyperplasia with squamous cell metaplasia (BCH+SM+D-) and squamous cell metaplasia with dysplasia (BCH-SM+D+) were identified in the bronchial epithelium of small bronchi taken at a distance of 3–5 cm from the tumor. Preliminary studies have shown that the detection of BCH+SM-D- or BCH-SM+D-in small bronchi are the markers of high risk of NSCLC distant metastasis, and the detection of BCH+SM+D- and BCH-SM-D- are the markers of low risk of NSCLC distant metastasis. 52.6 % of patients (90/171) received 2–3 courses of neoadjuvant chemotherapy (NAC), 41.1 % (37/90) of patients underwent intraoperative radiation therapy (IORT) at a single dose of 10–15 Gy and 47.4 % (81/171) of patients received platinum-based adjuvant chemotherapy (AC).Results. Both treatment options (NAC+IORT+ and NAC+IORT–) effectively reduced the incidence of distant metastases in the high-risk group patients during the first 2 years of follow-up compared with the high-risk group patients who did not received therapy. In the low-risk group patients, distant metastases rarely occurred, regardless of the treatment option. Adjuvant chemotherapy was found to have no influence on the frequency of distant metastases. Metastasis-free and overall survival rates were better in the low-risk group patients or in patients who received the NAC+IORT+ regimen.Conclusion. Combination of NAC and IORT resulted in the increase in metastasis-free and overall survival rates.

10 December 2023 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
MZMarina V. Zavyalova
Marina V. Zavyalova
GKGleb A. Kuznecov
Gleb A. Kuznecov
EGEvgeniya Grigoryeva
Evgeniya Grigoryeva
LTLiubov Tashireva
Liubov Tashireva
DPDmitry S. Pismenny
Dmitry S. Pismenny
VPVladimir Perelmuter
Vladimir Perelmuter
Background. Breast cancer ranks first in the structure of cancer morbidity and mortality. Involvement of a large number of regional lymph nodes is considered a poor prognostic outcome. The mechanisms of development of lymphogenous metastasis in general and common in particular are not fully understood. Integrins are involved in the metastatic process by mediating tumor cell invasion and adhesion to vascular endothelium. Aim. To study the role of integrins in lymphogenous metastasis. Materials and methods. The study included 72 patients diagnosed with invasive breast carcinoma of no special type who underwent surgical treatment on the basis of the cancer research institute national research medical center. The average age reached 51.2 years. In accordance with the indications and morphological data, the patients underwent antitumor treatment. The tissue of the primary tumor obtained by trepanbiopsy. Histological and immunohistochemical examination was carried out according to the standard method. In primary tumor cells, the presence or absence of cytoplasmic or membrane/cytoplasmic colocalization of CD61 (Integrin beta 3), CD104 (Integrin beta 4), CD51 (Integrin alpha-V) expression was assessed. When statistically processing the results, Fisher's test and one-way regression analysis were used. Results. In the N3 group, the frequency of cytoplasmic expression of CD 61 was higher at the trend level (40.9 and 18%; p=0.074). In the group of patients with N3, positive cytoplasmic expression of CD104 (37.5 and 15.0%; p=0.029) and membrane and cytoplasmic colocalization (52.6 and 15.1%; p=0.004) were more often detected. In the group with N1 and N2, membrane and cytoplasmic colocalization of CD104 expression was less common (15.8 and 54.7%; p=0.006). When studying the expression frequency of CD51 integrin, no significant differences were found depending on the severity of lymphogenous metastasis. Conclusion. Expression of CD104 in primary tumor cells is strongly associated with widespread lymphogenous metastasis. Studies of the role of integrins in the development of lymphogenous metastasis are promising for predicting the prevalence of this process in the preoperative period and for searching for methods of influencing the tumor.

29 October 2022 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
MZM. V. Zavyalova
M. V. Zavyalova
DLD. M. Loos
D. M. Loos
ДПД. С. Письменный
Д. С. Письменный
ADA. A. Durova
A. A. Durova
EAE. S. Andryukhova
E. S. Andryukhova
VPVladimir Perelmuter
Vladimir Perelmuter
The aim of the study: to examine the relationship between the morphological diversity of non-small cell lung cancer and the frequency of lymph node metastasis in groups of patients with different epithelial conditions in the bronchi adjacent to the tumor. Material and methods. Surgical specimens from 90 patients with non-small cell lung cancer, who were treated in the Thoracoabdominal Department Of The Research Institute Of Oncology Of The Tomsk National Research Medical Center in the period from 2009 to 2017 were studied. The histological type of cancer was determined according to the who classification (2020). Lepidic, acinar, papillary, micropapillary, solid and solitary tumor cells were isolated in the parenchymal component of adenocarcinoma. In the parenchymal component of squamous cell carcinoma, 5 types of structures were distinguished: with keratinization, consisting of atypical cells of the prickly type without keratinization, consisting of atypical cells of the basaloid type, built of atypical cells with pronounced polymorphism, single tumor cells. Results. In patients with isolated basal cell hyperplasia, acinar (37 %), papillary (29 %) and solid (27 %) patterns were found less frequently in cases with metastatic regional lymph nodes compared to those without metastatic lymph nodes (63 %; p=0.05; 71 %; p=0.05; 73 %; p=0.01, respectively). In patients with isolated basal cell hyperplasia of the bronchial epithelium, in cases with the presence of lymph node metastasis in the parenchymal component of squamous cell carcinoma, structures 1 (with keratinization) (17 %), 2 (spiky pattern) (33 %) and 4 (polymorphic pattern) (29 %) were less frequently detected compared to those without metastases in regional lymph nodes (83 %; p=0.01; 67 %; p=0.02 and 71 %; p=0.01, respectively). In patients with a combination of basal cell hyperplasia and squamous metaplasia, a spiny pattern (65 %), a basaloid pattern (100 %), a polymorphic pattern (82 %) and single tumor cells (89 %) were more frequently detected in cases with metastatic lymph nodes than in cases without metastatic lymph nodes (35 %; р=0.04; 0 %; р=0.01; 18 %; р=0.01; 11 %; р=0.01, respectively). Conclusion. The data obtained clarify the available information on the significance of the morphological heterogeneity of the tumor for predicting the course of adenocarcinoma and squamous cell carcinoma of the lung.

30 December 2024 in Yakut Medical Journal
Verified
Journal Article
Closed access
YPYu.M. Paderov
Yu.M. Paderov
KMKh.L. Mavidi
Kh.L. Mavidi
LZLilia D. Liliia Dmitrievna Zhuykova
Lilia D. Liliia Dmitrievna Zhuykova
LPL.V. Pikalova
L.V. Pikalova
MZM.V. Zavyalova
M.V. Zavyalova
OAO.A. Ananina
O.A. Ananina
Multiple primary malignant tumors are independent occurrence and development of two or more neoplasms in one patient. In this case, not only different organs of different systems can be affected, but also paired organs, as well as one organ multicentrically. Carcinogenesis is based on a multistage process of changes, malignant transformation and progression, which includes DNA damage and dysfunction of the immune system. Damage to certain parts of genes involved in mitosis, cell death or DNA repair is reflected in an increase in the mutation load. After accumulation of a sufficient number of mutations, control over cell function is disrupted, which leads to the development of cancer. In recent years, an increase in the frequency of multiple primary neoplasms has been noted. The review presents the main risk factors that to one degree or another affect the development of polyneoplasia. Keywords: multiple primary malignant neoplasms, polyneoplasia, risk factors

1 October 2026 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
VPVladimir Perelmuter
Vladimir Perelmuter
AZA. V. Zavyalov
A. V. Zavyalov
EGEvgeniya Grigoryeva
Evgeniya Grigoryeva
OSOlga Savelieva
Olga Savelieva
EGE. Yu. Garbukov
E. Yu. Garbukov
МЗМ. В. Завьялова
М. В. Завьялова
Aim. To study the co-expression patterns of molecular biological subtype (MBS) markers on individual circulating tumor cells (CTCs) in luminal subtypes of breast cancer (BC) and their association with the expression of stemness and epithelial – mesenchymal transition (EMT) markers. Materials and methods. The study analyzed venous blood and primary tumor biopsies from 51 BC patients (N1– 4N0–3M0), including 21 cases with luminal A, 19 cases with luminal B (HER2–), and 11 cases with luminal B (HER2+) MBS. Flow cytometry was used to assess the expression of CD45, EpCAM, N-/E-cadherin, CD44, CD24, CD133, Her2neu, ER, PR, and Ki67 in CTCs before therapy initiation. Statistical analysis was performed using Statistica 10.0 ( p < 0.05). Results. In luminal A and B (HER2–) primary tumor MBS, phenotypic conversion of CTCs was observed, characterized by the emergence of HER2+ CTCs, which were often ER-negative and exhibited various coexpression patterns of stemness markers. The key practical finding was the identification of a metastasis-associated CTC phenotype in luminal HER2– MBS: CD45–EpCAM+ER–PR–Her2neu+Ki67–. This phenotype corresponds to the classical HER2+ subtype at the level of a single cell. Conclusion. The study results support the feasibility of determining MBS marker expression on a single CTC for predicting the risk of hematogenous metastasis in luminal A and B (HER2–) primary tumor MBS and for optimizing treatment strategies.

19 June 2026 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
MZM. V. Zavyalova
M. V. Zavyalova
ЗВЗавьялова М. В.
Завьялова М. В.
GKG. A. Kuznetsov
G. A. Kuznetsov
КАКузнецов Г. А.
Кузнецов Г. А.
AZA. V. Zavyalov
A. V. Zavyalov
ПМПерельмутер В. М.
Перельмутер В. М.
Laminins are a family of high-molecular-weight heterotrimeric glycoproteins of the extracellular matrix that play a key structural role in basement membranes. Although mutations in intracellular proteins remain the primary drivers of carcinogenesis, the role of changes in the expression and spatial distribution of laminins in the development of malignant neoplasms is gaining increasing importance. Primary focus is given to the patterns of laminin alterations in carcinomas of various localizations, as well as their role in the acquisition of invasive and metastatic potential by tumor cells. Furthermore, the prognostic significance of different laminin isoforms is discussed.